Quaker Chemical Corporation (KWR)

NYSEMaterialsChemicals - SpecialtySnapshot 2026-10-23

$155.91-0.42%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Quaker Chemical Corporation’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

+0.6%

+10% or more+5%0%−5%−10% or less

9.51 → 9.56 EPS · FY ending Dec 31, 2027 · 5 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 24, 2026 to Oct 24, 2026: (new ÷ prior − 1). Contributor count changed from 5 to 5; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	499.28M
EPS	—	1.804
Annual ending 2026-12-31
Revenue	—	2.03B
EPS	—	7.867
Annual ending 2027-12-31
Revenue	—	2.13B
EPS	—	9.563

Management figures unavailable.

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Gross profit margin improvement with at least $15 million increase next four quarters	Gross profit rose $15 million last year.	Intact	Gross profit increase falls below $15 million next year	Gross profit: $189.204M FY2026-Q2; GAAP. Published target: >= $15 million gross profit increase. Target period is not explicitly aligned with this observation. Source published Jul 30, 2026189,204,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 276310a1-535d-4819-819a-350e443a02c5. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Net cash from operations at least $3.8 million next four quarters	Cash flow from operations improved to $3.8 million in Q1.	Intact	Operating cash flow falls below $3.8 million next year	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated in 3 of last 3 quarters. Operating cash flow was $136.5M in 2025 and $33.2M in first half 2026, reflecting improved operating performance but lower cash flow year-over-year. Net debt remained stable at $721M with leverage at 2.3x adjusted EBITDA. Management has extended debt maturity and increased credit availability, showing mixed progress on liquidity. Delivery assessment Oct 24, 2026
Year-over-year revenue growth of at least 6% next four quarters	A primary condition in Quaker Chemical Corporation's published investment case. The stated target is >=6% YoY revenue growth.	Intact	YoY revenue growth falls below 6% next year	Revenue growth: 10.17% FY2026-Q2; GAAP. Published target: >=6% YoY revenue growth. Target period is not explicitly aligned with this observation. Source published Jul 30, 202610.167563 percent · calculatedSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 276310a1-535d-4819-819a-350e443a02c5. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 4 of last 4 quarters. Revenue grew from $468.5M in 2025-Q4 to $532.6M in 2026-Q2, driven by volume growth of 7% Y/Y in 2026-Q2 and new business wins across all segments. Management consistently emphasized new business wins and share gains, and the trajectory is delivering. Delivery assessment Oct 24, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$9.56

$8.76 → $9.56 · observed estimates

FY2027 revenue$2.13B

$2.08B → $2.13B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$8.76	$2,081,781,370	7 / 7
2026-07-25	Unavailable	$2,081,748,145	4 / 6
2026-07-26	$8.76	$2,081,781,370	7 / 7
2026-07-27	Unavailable	$2,081,805,288	4 / 6
2026-07-28	Unavailable	$2,081,805,288	4 / 6
2026-07-29	$8.76	$2,081,781,370	7 / 7
2026-07-30	$8.76	$2,081,781,370	7 / 7
2026-07-31	$8.76	$2,081,781,370	7 / 7
2026-08-01	Unavailable	$2,081,805,288	4 / 6
2026-08-02	$8.76	$2,081,781,370	7 / 7
2026-08-03	$8.98	$2,087,624,230	7 / 7
2026-08-04	$8.98	$2,087,624,230	7 / 7
2026-08-05	$9.25	$2,096,938,510	7 / 7
2026-08-06	$8.98	$2,087,641,095	5 / 6
2026-08-07	$8.98	$2,087,641,095	5 / 6
2026-08-08	$9.30	$2,101,224,230	7 / 7
2026-08-09	$8.98	$2,087,641,095	5 / 6
2026-08-10	$9.30	$2,101,224,230	7 / 7
2026-08-12	$8.98	$2,087,641,095	5 / 6
2026-08-13	$8.98	$2,087,641,095	5 / 6
2026-08-14	$8.98	$2,087,641,095	5 / 6
2026-08-15	$8.98	$2,087,641,095	5 / 6
2026-08-16	$8.98	$2,087,641,095	5 / 6
2026-08-17	$8.98	$2,087,641,095	5 / 6
2026-08-18	$8.98	$2,087,641,095	5 / 6
2026-08-19	$8.98	$2,087,641,095	5 / 6
2026-08-20	$9.41	$2,115,614,286	5 / 6
2026-08-21	$9.41	$2,115,614,286	5 / 6
2026-08-22	$9.41	$2,115,614,286	5 / 6
2026-08-23	$9.41	$2,115,614,286	5 / 6
2026-08-24	$9.41	$2,115,614,286	5 / 6
2026-08-25	$9.41	$2,115,614,286	5 / 6
2026-08-26	$9.51	$2,124,471,429	5 / 6
2026-08-27	$9.51	$2,124,471,429	5 / 6
2026-08-28	$9.51	$2,124,471,429	5 / 6
2026-08-29	$9.51	$2,124,471,429	5 / 6
2026-08-30	$9.51	$2,124,471,429	5 / 6
2026-08-31	$9.51	$2,124,471,429	5 / 6
2026-09-01	$9.51	$2,124,471,429	5 / 6
2026-09-02	$9.51	$2,124,471,429	5 / 6
2026-09-03	$9.51	$2,124,471,429	5 / 6
2026-09-04	$9.51	$2,124,471,429	5 / 6
2026-09-05	$9.51	$2,124,471,429	5 / 6
2026-09-06	$9.51	$2,124,471,429	5 / 6
2026-09-07	$9.51	$2,124,471,429	5 / 6
2026-09-08	$9.51	$2,124,471,429	5 / 6
2026-09-09	$9.51	$2,124,471,429	5 / 6
2026-09-10	$9.51	$2,124,471,429	5 / 6
2026-09-11	$9.51	$2,124,471,429	5 / 6
2026-09-12	$9.51	$2,124,471,429	5 / 6
2026-09-13	$9.51	$2,124,471,429	5 / 6
2026-09-14	$9.51	$2,124,471,429	5 / 6
2026-09-15	$9.51	$2,124,471,429	5 / 6
2026-09-16	$9.51	$2,124,471,429	5 / 6
2026-09-17	$9.51	$2,124,471,429	5 / 6
2026-09-18	$9.51	$2,124,471,429	5 / 6
2026-09-19	$9.51	$2,124,471,429	5 / 6
2026-09-20	$9.51	$2,124,471,429	5 / 6
2026-09-21	$9.51	$2,124,471,429	5 / 6
2026-09-22	$9.51	$2,124,471,429	5 / 6
2026-09-23	$9.51	$2,124,471,429	5 / 6
2026-09-24	$9.51	$2,124,471,429	5 / 6
2026-09-25	$9.51	$2,124,471,429	5 / 6
2026-09-26	$9.51	$2,124,471,429	5 / 6
2026-09-27	$9.51	$2,124,471,429	5 / 6
2026-09-28	$9.51	$2,124,471,429	5 / 6
2026-09-29	$9.51	$2,124,471,429	5 / 6
2026-09-30	$9.51	$2,124,471,429	5 / 6
2026-10-01	$9.53	$2,124,471,429	5 / 6
2026-10-02	$9.53	$2,124,471,429	5 / 6
2026-10-03	$9.53	$2,124,471,429	5 / 6
2026-10-04	$9.53	$2,124,471,429	5 / 6
2026-10-05	$9.53	$2,124,471,429	5 / 6
2026-10-06	$9.53	$2,124,471,429	5 / 6
2026-10-07	$9.53	$2,124,471,429	5 / 6
2026-10-08	$9.53	$2,124,471,429	5 / 6
2026-10-09	$9.53	$2,124,471,429	5 / 6
2026-10-10	$9.53	$2,124,471,429	5 / 6
2026-10-11	$9.53	$2,124,471,429	5 / 6
2026-10-12	$9.53	$2,124,471,429	5 / 6
2026-10-13	$9.53	$2,124,471,429	5 / 6
2026-10-14	$9.53	$2,124,471,429	5 / 6
2026-10-15	$9.53	$2,124,471,429	5 / 6
2026-10-16	$9.56	$2,126,914,286	5 / 6
2026-10-17	$9.56	$2,126,914,286	5 / 6
2026-10-18	$9.56	$2,126,914,286	5 / 6
2026-10-19	$9.56	$2,126,914,286	5 / 6
2026-10-20	$9.56	$2,126,914,286	5 / 6
2026-10-21	$9.56	$2,126,985,714	5 / 6
2026-10-22	$9.56	$2,126,985,714	5 / 6
2026-10-23	$9.56	$2,126,985,714	5 / 6
2026-10-24	$9.56	$2,126,985,714	5 / 6

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	6	0	0
2026-06-01	7	0	0
2026-07-01	7	0	0
2026-08-01	7	0	0
2026-09-01	7	0	0
2026-10-01	7	0	0

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 7 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades2 maintains

Recent actions · Sep 25–Oct 24 · 2 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

RBC CapitalOct 15 · prior Aug 3

$198.00 → $202.00+2.0%

$0$111.10$222.20

1 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Gross profit margin improvement with at least $15 million increase next four quartersGross profit: $189.204M
Net cash from operations at least $3.8 million next four quartersDirect metric needs a verified mapping
Year-over-year revenue growth of at least 6% next four quartersRevenue growth: 10.17%

Next proof point

Oct 29, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.3%Typical daily move · historical

Downside history

-36.5%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Quaker Chemical Corporation outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

KWR is a growth-oriented industrial business with recent strong performance, rather than a turnaround story. Its long-term thesis is intact, and its signal has improved from mixed to mildly favorable, but management execution has been volatile.

What's priced into Quaker Chemical Corporation

Valuation is stretched, at a 1.27 premium to peers, and the evidence points to a small expectations gap. The valuation model has low confidence, so how much further expectations can rise is uncertain; fragility indicators are low.

What the fundamentals likely do

Near-term results have been strong: revenue rose from $468.5 million in 2025-Q4 to $532.6 million in 2026-Q2, with 7% year-over-year volume growth, while gross margin stayed near 35%. Cash generation is less consistent, and a CFO transition adds uncertainty; the next guidance update and peer results are near-term risks.

What Quaker Chemical Corporation hinges on

The multi-year thesis depends on continued new business wins and share gains, along with cost control that preserves margins. A guidance cut would be a meaningful negative, while continued strength from sector bellwethers LIN, SHW, and ECL could support the sector backdrop; weaker results from those peers could remove that support.